Evidence map›Paper›PMID 38472284›Full record

ArticleScientific reports2024

Investigating the prevalence of body dysmorphic disorder among Jordanian adults with dermatologic and cosmetic concerns: a case-control study.

Rand Murshidi, Muhammad Hammouri, Abdallah Al-Ani, Razi Kitaneh, Majd Al-Soleiti, Zain Al Ta'ani, Sami Sweis, Zeina Halasa, Eva Fashho, Malak Arafah and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Rand MurshidiDepartment of Dermatology, School of Medicine, The University of Jordan, Amman, Jordan.
Muhammad HammouriSchool of Medicine, The University of Jordan, Amman, Jordan. muhammad0hm@gmail.com.
Abdallah Al-AniOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.
Razi KitanehDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, 06519, USA.
Majd Al-SoleitiDepartment of Psychiatry and Psychology, Rochester, MN, USA.
Zain Al Ta'aniDepartment of Dermatology, School of Medicine, The University of Jordan, Amman, Jordan.
Sami SweisSchool of Medicine, The University of Jordan, Amman, Jordan.
Zeina HalasaSchool of Medicine, The University of Jordan, Amman, Jordan.
Eva FashhoSchool of Medicine, The University of Jordan, Amman, Jordan.
Malak ArafahSchool of Medicine, The University of Jordan, Amman, Jordan.
Noor AlmaaniDepartment of Dermatology, School of Medicine, The University of Jordan, Amman, Jordan.
Mahmoud AbdallatDepartment of Neurosurgery, School of Medicine, The University of Jordan, Amman, Jordan.
Faten Al-Dar'awiSchool of Medicine, The University of Jordan, Amman, Jordan.
Eman KittanehSchool of Medicine, The University of Jordan, Amman, Jordan.
Besan JaberSchool of Medicine, The University of Jordan, Amman, Jordan.
Farah AlmudallalSchool of Medicine, The University of Jordan, Amman, Jordan.
Zina SmadiSchool of Medicine, The University of Jordan, Amman, Jordan.
University of Jordan · JOKing Hussein Cancer Center · JOUniversity of Minnesota Rochester · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Body Dysmorphic Disorder (BDD) is an underexplored psychiatric condition in Middle Eastern countries, particularly in patients with dermatologic concerns, where alterations in appearance may elevate the risk of BDD. We studied patients at Jordan University Hospital's general dermatology and cosmetic clinics from July to September 2022, comparing them to healthy controls. Patients with dermatologic conditions were evaluated per the International Classification of Diseases (ICD-10) criteria by trained dermatologists. All participants completed the Dysmorphic Concerns Questionnaire (DCQ), Perceived Stress Scale, Patient Health Questionnaire-2, General Anxiety Disorder Assessment tool-2. We assessed BDD prevalence using four DCQ cutoffs: 9, 11, 14, and 17, reporting effect sizes as odds ratios (OR). Our study involved 1500 participants, with an average age of 29.3 (± 14.8) years and a female-to-male ratio of 3.15-to-1. At the 9, 11, 14, and 17 DCQ cutoffs, BDD prevalence was 78.2%, 54.2%, 26.5%, and 11.7%, respectively. Patients with dermatologic concerns were more likely to exhibit clinical BDD symptoms than controls at the 11-cutoff (OR: 1.26; 95% CI 1.01-1.58; p < 0.05). Conversely, those with cosmetic concerns were more prone to clinical BDD than controls at cutoffs 9 (OR: 2.26; 95% CI 1.28-3.97; p < 0.05) and 11 (OR: 1.50; 95% CI 1.03-2.20; p < 0.05). Our logistic regression revealed consistent associations between higher DCQ scores and elevated anxiety, depression, perceived skin disease-related stigma, and reduced quality of life (p < 0.05). In conclusion, patients with dermatologic issues and those seeking cosmetic procedures are at significant risk of developing BDD, necessitating proactive screening and referrals for specialized care by dermatologists due to the associated psychological distress and unproductive consultations. Providing specialized training for healthcare professionals to establish an integrated care approach to address the needs of patients with BDD should be the focus of future research projects.

Indexed as

Anxiety DisordersBody Dysmorphic DisordersPsychological TestsSelf ReportAdultCase-Control StudiesFemaleGeneralized Anxiety DisorderHumansJordanMalePrevalenceQuality of LifeSurveys and QuestionnairesBody dysmorphic disorderCosmetic dermatologyDermatologyJordanSkin disease

Identifiers

PMID38472284
PMCPMC10933333
OpenAlexW4392679447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.